Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue.
For decades, one of the biggest problems in brain cancer treatment has had little to do with killing cancer cells and everything to do with reaching them. The brain’s protective blood-brain barrier (BBB) blocks toxins and pathogens from entering the brain, but it also prevents many cancer drugs from getting through.
That challenge has helped make glioblastoma one of the deadliest forms of cancer, with most patients surviving little more than a year after diagnosis despite aggressive treatment.
Now, researchers report early evidence that a modified form of vitamin B12 may be able to slip through that barrier and deliver a cancer-fighting molecule directly into brain tumors.
The findings, published in Oncoscience, focus on nitrosylcobalamin (NO-Cbl), a nitric oxide-releasing vitamin B12 analog. The study was led by Joseph A. Bauer of Nitric Oxide Services, LLC and the Cleveland Clinic Foundation Taussig Cancer Center.
Evaluating NO-Cbl Across Multiple Models
Researchers tested NO-Cbl using several experimental methods, including the NCI-60 human tumor cell line panel, pharmacokinetic studies in rats with glioblastoma tumors, and combination therapy studies in human glioblastoma cell lines.
The results showed that NO-Cbl produced antitumor effects across multiple cancer types. Central nervous system tumor cell lines showed moderate sensitivity to the treatment.
Animal studies revealed that NO-Cbl successfully crossed the BBB after systemic administration and accumulated preferentially in glioblastoma tissue. Tumor nitrate levels stayed elevated for at least 24 hours after treatment, while nitrate levels in normal tissues declined more quickly. These findings suggest that the compound may provide targeted nitric oxide delivery within the tumor microenvironment.
They also showed sustained accumulation of nitrate and cobalamin-related metabolites in brain tumor tissue compared with other organs.
Enhanced Effects With Existing Therapies
The researchers also investigated whether NO-Cbl could improve the effectiveness of current glioblastoma treatments. In cultured U87 and D54 glioblastoma cells, combining NO-Cbl with TRAIL or temozolomide produced significantly greater suppression of tumor cell proliferation than either treatment alone.
Combination index analysis confirmed synergistic interactions across multiple dose ranges.
“This pilot study demonstrates that NO-Cbl crosses the BBB, accumulates selectively in brain tumor tissue, and synergizes with established and experimental glioblastoma therapies,” the authors say.
Possible Role in Overcoming Drug Resistance
The study also examined how NO-Cbl may help counter treatment resistance in glioblastoma. Previous research cited by the authors showed that the compound can trigger apoptosis through caspase-8 activation, suppress NF-κB survival signaling, and enhance TRAIL receptor signaling through S-nitrosylation.
Together, these mechanisms may improve treatment sensitivity, including in temozolomide-resistant glioblastoma models.
The authors emphasized that the work is an early translational pilot study and that more research will be needed before the approach can move toward clinical use. Future studies will focus on orthotopic validation, dose optimization, long-term nitric oxide tracking, and additional mechanistic studies in central nervous system tumor models.
Overall, the findings provide early evidence that a cobalamin-based nitric oxide donor could represent a new therapeutic strategy for glioblastoma. By combining BBB penetration, tumor-targeted nitric oxide delivery, and synergy with existing therapies, NO-Cbl may help improve drug delivery and reduce treatment resistance in one of the most difficult cancers in neuro-oncology.
Reference: “Selective blood-brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide” by Joseph A Bauer, Annette M Sysel and Michael J Dunphy, 2 April 2026, Oncoscience.
DOI: 10.18632/oncoscience.654
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
